107 related articles for article (PubMed ID: 7577078)
1. Epidermal growth factor receptor expression by northern analysis and immunohistochemistry in benign and malignant prostatic tumours.
Harper ME; Goddard L; Glynne-Jones E; Peeling WB; Griffiths K
Eur J Cancer; 1995; 31A(9):1492-7. PubMed ID: 7577078
[TBL] [Abstract][Full Text] [Related]
2. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues.
Ibrahim GK; Kerns BJ; MacDonald JA; Ibrahim SN; Kinney RB; Humphrey PA; Robertson CN
J Urol; 1993 Jan; 149(1):170-3. PubMed ID: 7678041
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue.
Turkeri LN; Sakr WA; Wykes SM; Grignon DJ; Pontes JE; Macoska JA
Prostate; 1994 Oct; 25(4):199-205. PubMed ID: 7521960
[TBL] [Abstract][Full Text] [Related]
4. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
Maygarden SJ; Strom S; Ware JL
Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
[TBL] [Abstract][Full Text] [Related]
5. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
[TBL] [Abstract][Full Text] [Related]
6. In situ hybridization for epidermal growth factor receptor (EGFR) external domain transcripts in prostatic adenocarcinoma.
Montone KT; Tomaszewski JE
J Clin Lab Anal; 1993; 7(3):188-95. PubMed ID: 7685381
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
Glynne-Jones E; Goddard L; Harper ME
Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies.
Hakalahti L; Vihko P; Henttu P; Autio-Harmainen H; Soini Y; Vihko R
Int J Cancer; 1993 Oct; 55(4):590-7. PubMed ID: 7691762
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
12. Differential immunoreactivity of transforming growth factor alpha in benign, dysplastic and malignant prostatic tissues.
Robertson CN; Roberson KM; Herzberg AJ; Kerns BJ; Dodge RK; Paulson DF
Surg Oncol; 1994 Aug; 3(4):237-42. PubMed ID: 7530564
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors.
Glynne-Jones E; Harper ME; Goddard L; Eaton CL; Matthews PN; Griffiths K
Prostate; 1994 Oct; 25(4):210-8. PubMed ID: 7521962
[TBL] [Abstract][Full Text] [Related]
14. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
Ravindranath N; Wion D; Brachet P; Djakiew D
J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of c-erbB-2 and epidermal growth factor receptor in stage A1 (T1a) prostatic adenocarcinoma.
Fox SB; Persad RA; Coleman N; Day CA; Silcocks PB; Collins CC
Br J Urol; 1994 Aug; 74(2):214-20. PubMed ID: 7921940
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate.
Kumar VL; Majumder PK; Gujral S; Kumar V
Cancer Lett; 1998 Dec; 134(2):177-80. PubMed ID: 10025878
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor and transforming growth factor alpha expression in human ovarian carcinomas.
Kohler M; Bauknecht T; Grimm M; Birmelin G; Kommoss F; Wagner E
Eur J Cancer; 1992; 28A(8-9):1432-7. PubMed ID: 1515265
[TBL] [Abstract][Full Text] [Related]
19. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate.
Kaplan PJ; Leav I; Greenwood J; Kwan PW; Ho SM
Carcinogenesis; 1996 Dec; 17(12):2571-9. PubMed ID: 9006091
[TBL] [Abstract][Full Text] [Related]
20. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
